Health Evidence Network synthesis report 53
This publication by UNAIDS, UNDP and the International Organisation for Migration examines various dimensions related to migration and HIV and AIDS.
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
A process for improving community awareness and preparedness for technological hazards and environmental emergencies
Infant Psychiatry
Chapter B.1
Early Maltreatment and exposure to violence
Impact of EU policies on accessing protection. The report highlights the tragedy hundreds of thousands of people face when seeking protection in Europe. Women, men and children escaping war, repression and violation of human rights often turn to Europe in the hope of finding a safe haven. But many a...re instead confronted with bureaucratic hurdles, denial of protection and inconsistent reception standards across Europe.
more
The Guide has been developed to enhance the knowledge capabilities of NDMAs and their local partners. This is accomplished by exposing them to the existing tools and services developed by the international community to facilitate effective disaster response to any scale of disaster (small, medium an...d large) and assist in comprehensive response preparedness
more
Mood disorders
Chapter E.2
What are the political, economic, social and security implications of the Ebola crisis, with a particular focus on Sierra Leone?
Zero Draft for Consultation, 3rd Version, November 2015
This paper examines how diaspora and local organisations have responded to the crisis in Syria, how they evolved and the challenges that they face - and how international aid organisations and disapora and local groups can better work together in a new aid model.
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to... understand the nature and extent of oxytocin quality issues and to provide key technical information and quality requirements for oxytocin products in dossier assessments. Furthermore, this document also presents recommendations on other regulatory actions needed to ensure that only quality-assured oxytocin products are authorized and made available to women.
more